Dasatinib + Quercetin (Senolytic Stack) vs Vitamin C (Liposomal)

Mechanism

Dasatinib is a multi-kinase inhibitor (targeting SRC, ABL, c-KIT, PDGFR, and ephrin receptors) originally developed for chronic myeloid leukemia. Quercetin is a natural flavonoid that inhibits PI3K, serpine/PAI-2, BCL-xL, and other anti-apoptotic pathways. Together, they constitute a senolytic combination that selectively induces apoptosis in senescent cells by disabling the senescent cell anti-apoptotic pathways (SCAPs) that allow damaged, non-dividing cells to resist programmed cell death. Senescent cells accumulate with aging and secrete the SASP (senescence-associated secretory phenotype) — inflammatory cytokines, matrix metalloproteinases, and growth factors that drive tissue dysfunction. By clearing senescent cells, D+Q reduces SASP-driven chronic inflammation.

Standard Dosing

Research indicates Dasatinib 100 mg + Quercetin 1000-1250 mg orally for 2 consecutive days, repeated every 2-4 weeks (intermittent 'hit-and-run' dosing).

Timing

Take both compounds together on dosing days, with or without food. The 'hit-and-run' approach exploits the fact that senolytic effect occurs rapidly but senescent cells take weeks to re-accumulate. Quercetin bioavailability is improved by fat co-ingestion.

Cycle Duration

Ongoing intermittent cycles. Long-term safety data in healthy populations is limited. Typically used in periodic courses (e.g., 2 days per month for 3-6 months, then reassess).

Side Effects

• GI discomfort, nausea, diarrhea (both compounds)
• Fluid retention and peripheral edema (dasatinib)
• Headache
• Thrombocytopenia and neutropenia (dasatinib — typically mild at senolytic doses)
• Pleural effusion (rare at intermittent dosing; more common with chronic oncology dosing)
• Skin rash

Contraindications

• Active bleeding disorders or thrombocytopenia
• Severe hepatic impairment
• Pulmonary arterial hypertension
• QT prolongation risk or concurrent QT-prolonging drugs
• Pregnancy and breastfeeding
• Active infections (temporary immunosuppression)

Best Stacking Partners

Mechanism

Ascorbic acid is an essential electron donor and cofactor for numerous enzymatic reactions. It is required for collagen synthesis (prolyl and lysyl hydroxylases), carnitine biosynthesis, catecholamine synthesis (dopamine beta-hydroxylase), and alpha-ketoglutarate-dependent dioxygenases including HIF-prolyl hydroxylases and TET methylcytosine dioxygenases (epigenetic regulation). It regenerates oxidized vitamin E, supports immune function via neutrophil chemotaxis, phagocytosis, and lymphocyte proliferation. Liposomal delivery bypasses SVCT1/2 transporter saturation, achieving plasma levels closer to IV administration.

Standard Dosing

1000-2000mg liposomal vitamin C daily

Timing

Divided doses throughout the day (every 4-6 hours) for optimal plasma levels. Away from high-dose minerals.

Cycle Duration

ongoing

Side Effects

• Diarrhea/GI upset at high non-liposomal doses (bowel tolerance)
• Kidney stone risk (oxalate pathway)
• False blood sugar readings on glucometers
• Dental erosion (chewable forms)

Contraindications

• Hemochromatosis (enhances iron absorption)
• G6PD deficiency (high-dose IV can cause hemolytic anemia)
• History of calcium oxalate kidney stones (may increase oxalate at high oral doses)
• Renal insufficiency (accumulation risk)

Best Stacking Partners